Optimum Clinical Research is categorized under Medical Research in Salt Lake City, UT and active since 2012.
Optimum Clinical Research was established in 2012, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 5417110 by the NAICS.
If you are seeking more information, feel free to contact Jackson Rhudy, Owner at the company’s single location by writing to 82 South 1100 East # 402, Salt Lake City, Utah UT 84102 or by phoning (801) 363-7353. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Optimum Clinical Research |
| Contact Person: | Jackson Rhudy, Owner |
| Address: | 82 South 1100 East # 402, Salt Lake City, Utah 84102 |
| Phone Number: | (801) 363-7353 |
| Website Address: | ocresearch.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 5417110 |
| Share This Business: |
Optimum Clinical Research was started in 2012 to provide professional Medical Research under the SIC code 8733 and NAICS code 5417110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Jackson Rhudy, Owner for inquiries that concern Optimum Clinical Research by calling the company number (801) 363-7353, as your correspondence is most welcome. Additionally, the physical location of the single location of Optimum Clinical Research can be found at the coordinates 40.767588,-111.859656 as well as the street address 82 South 1100 East # 402 in Salt Lake City, Utah 84102.
For its online presence, you may visit Optimum Clinical Research’s website at ocresearch.com and engage with its social media outlets through on Twitter and on Facebook.